Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 112.58%1.11B | 113.64%752.74M | 104.57%350.42M | -2.92%688.38M | -1.47%521.84M | -2.22%352.34M | -10.55%171.3M | -3.82%709.12M | -3.94%529.62M | -4.46%360.35M |
| Operating revenue | 112.58%1.11B | 113.64%752.74M | 104.57%350.42M | -2.92%688.38M | -1.47%521.84M | -2.22%352.34M | -10.55%171.3M | -3.82%709.12M | -3.94%529.62M | -4.46%360.35M |
| Other operating revenue | ---- | -9.46%1.37M | ---- | 59.47%2.97M | ---- | 31.04%1.51M | ---- | -39.16%1.86M | ---- | 139.07%1.15M |
| Total operating cost | 129.44%1.1B | 134.67%750.39M | 126.42%350.01M | 2.19%634.34M | 4.56%479.54M | 3.43%319.76M | -3.89%154.58M | -5.54%620.72M | -5.78%458.63M | -5.36%309.16M |
| Operating cost | 135.71%1.04B | 139.62%708.83M | 132.40%331.47M | 2.67%581.75M | 5.23%441.42M | 4.65%295.81M | -3.29%142.62M | -6.05%566.62M | -5.43%419.48M | -5.37%282.66M |
| Operating tax surcharges | 49.06%5.13M | 77.76%4.06M | 79.08%2.05M | -17.37%4.14M | -4.49%3.44M | -2.43%2.28M | -1.32%1.15M | 32.11%5.01M | 16.28%3.61M | 20.96%2.34M |
| Operating expense | 83.60%16.37M | 103.93%12.18M | 107.62%6.16M | -12.10%10.55M | -0.23%8.91M | 0.31%5.97M | 7.73%2.97M | 9.91%12M | 18.48%8.94M | 20.96%5.95M |
| Administration expense | 39.16%32.56M | 59.65%23.39M | 50.96%10.17M | 15.14%35.16M | 3.29%23.4M | -9.98%14.65M | -6.67%6.74M | -5.54%30.53M | -16.34%22.65M | -6.34%16.28M |
| Financial expense | -17.40%-1.41M | -57.42%-2.14M | -1,193.72%-1.51M | -61.61%-2.34M | -2.01%-1.2M | 10.57%-1.36M | -120.85%-116.63K | -350.58%-1.45M | -304.22%-1.18M | -356.12%-1.52M |
| -Interest expense (Financial expense) | -18.75%1.89M | -41.01%937.71K | -40.41%451.73K | -41.20%1.81M | -2.51%2.32M | -0.36%1.59M | -22.89%758.12K | -17.76%3.08M | -17.78%2.38M | -20.78%1.6M |
| -Interest Income (Financial expense) | 43.95%-2.17M | 38.33%-1.72M | -29.79%-1.19M | -38.60%-4.25M | -55.77%-3.88M | -58.21%-2.78M | -92.07%-913.8K | -50.65%-3.07M | -56.38%-2.49M | -28.51%-1.76M |
| Research and development | 99.68%7.12M | 69.49%4.07M | 35.95%1.66M | -36.51%5.08M | -30.51%3.57M | -30.54%2.4M | -27.21%1.22M | 25.13%8M | 4.68%5.13M | 9.58%3.45M |
| Credit Impairment Loss | 1,078.12%446.07K | -326.14%-1.97M | 362.15%829.81K | -116.78%-264.67K | 64.91%-45.6K | -189.48%-461.13K | 53.65%-316.54K | -746.87%-122.09K | -128.63%-129.95K | 370.96%515.32K |
| Asset Impairment Loss | -438.39%-963.6K | ---26.89K | ---- | 84.57%-310.02K | 82.47%-178.98K | ---- | ---- | -120.73%-2.01M | -123.45%-1.02M | -123.45%-1.02M |
| Other net revenue | 16.60%2.26M | -23.81%115.93K | 641.92%1.38M | 90.19%1.88M | 2,417.99%1.94M | -66.18%152.15K | 34.85%-254.02K | -61.91%986.38K | -96.98%76.85K | -72.52%449.86K |
| Fair value change income | -123.27%-154.56K | 0.61%-68.8K | ---- | -11.38%-46.62K | -1,431.21%-69.22K | ---69.22K | ---- | -292.65%-41.86K | -232.43%-4.52K | ---- |
| Invest income | -82.21%357.61K | -93.33%39.97K | ---85.39K | -8.29%2.02M | 100.79%2.01M | -25.02%599.54K | ---- | -18.04%2.2M | -51.18%1M | -54.87%799.61K |
| Asset deal income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8.89K | ---- | ---- |
| Other revenue | 1,076.54%2.57M | 2,475.51%2.14M | 911.12%632.16K | -49.66%477.21K | -5.33%218.51K | -46.70%82.96K | -26.64%62.52K | 17.80%947.94K | -53.02%230.81K | -26.71%155.66K |
| Operating profit | -74.41%11.32M | -92.45%2.47M | -89.13%1.79M | -37.44%55.92M | -37.76%44.23M | -36.62%32.73M | -45.60%16.46M | 7.97%89.39M | 5.87%71.07M | -0.93%51.64M |
| Add:Non operating Income | 1,352.14%1.01M | 1,540.32%998.04K | 6,507.09%251.07K | 307,160.11%255.29M | -29.42%69.54K | 191.12%60.84K | 72.73%3.8K | 222.91%83.08K | 542.71%98.53K | 206.00%20.9K |
| Less:Non operating expense | 61,140.58%297.17K | --51.84K | --50.26K | -21.57%100.55K | -98.72%485.25 | ---- | ---- | -47.12%128.2K | -66.29%37.81K | -74.95%25.05K |
| Total profit | -72.84%12.03M | -89.58%3.42M | -87.91%1.99M | 248.23%311.11M | -37.71%44.3M | -36.50%32.79M | -45.56%16.47M | 8.20%89.34M | 6.12%71.13M | -0.76%51.64M |
| Less:Income tax cost | -62.94%3.82M | -58.90%3.16M | -70.84%1.17M | -35.70%13.37M | -39.95%10.31M | -37.81%7.69M | -45.86%4.02M | 10.76%20.79M | 5.88%17.18M | -0.49%12.36M |
| Net profit | -75.84%8.21M | -98.97%257.69K | -93.42%818.77K | 334.35%297.74M | -37.00%33.99M | -36.08%25.1M | -45.46%12.45M | 7.45%68.55M | 6.19%53.95M | -0.85%39.27M |
| Net profit from continuing operation | -75.84%8.21M | -98.97%257.69K | -93.42%818.77K | 334.35%297.74M | -37.00%33.99M | -36.08%25.1M | -45.46%12.45M | 7.45%68.55M | 6.19%53.95M | -0.85%39.27M |
| Net profit of parent company owners | -75.84%8.21M | -98.97%257.69K | -93.42%818.77K | 334.35%297.74M | -37.00%33.99M | -36.08%25.1M | -45.46%12.45M | 7.45%68.55M | 6.19%53.95M | -0.85%39.27M |
| Earning per share | ||||||||||
| Basic earning per share | -75.83%0.0569 | -98.96%0.0018 | -93.39%0.0057 | 334.39%2.0625 | -37.01%0.2354 | -36.09%0.1739 | -45.48%0.0862 | 7.45%0.4748 | 6.19%0.3737 | -0.84%0.2721 |
| Diluted earning per share | -75.83%0.0569 | -98.96%0.0018 | -93.39%0.0057 | 334.39%2.0625 | -37.01%0.2354 | -36.09%0.1739 | -45.48%0.0862 | 7.45%0.4748 | 6.19%0.3737 | -0.84%0.2721 |
| Other composite income | ||||||||||
| Total composite income | -75.84%8.21M | -98.97%257.69K | -93.42%818.77K | 334.35%297.74M | -37.00%33.99M | -36.08%25.1M | -45.46%12.45M | 7.45%68.55M | 6.19%53.95M | -0.85%39.27M |
| Total composite income of parent company owners | -75.84%8.21M | -98.97%257.69K | -93.42%818.77K | 334.35%297.74M | -37.00%33.99M | -36.08%25.1M | -45.46%12.45M | 7.45%68.55M | 6.19%53.95M | -0.85%39.27M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.